- 1 day ago
Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL
Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with...
- 2 days ago
Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma
A new report led by researchers at Baylor College of Medicine evaluates the association of germline CPVs with rhabdomyosarcoma outcomes...
- 3 days ago
Researchers turn back the clock on cancer cells to offer new treatment paradigm
Scientists at St. Jude Children’s Research Hospital discovered that removing a second protein from cancer cells already experiencing...
- 6 days ago
Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments
One of the research focal points of Dr. Josep Samitier's group (Nanobioengineering Group of IBEC), led by Dr. Aránzazu Villasante, is the...
- Apr 18
Longer exclusive breastfeeding may lower risk for childhood hematologic cancers
Exclusive breastfeeding duration of at least three months may decrease the risk for childhood hematologic cancers, according to a study...
- Apr 17
Predicting Infection Risk in Childhood Cancer
A statistical model can accurately predict the risk of bloodstream infections in a subset of children with cancer, according to a study...
- Apr 16
Researchers find genetic variant contributing to disparities in childhood leukemia risk
Acute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in...
- Apr 15
Chemotherapy cured my cancer. Years later it likely gave me heart disease.
The link is not uncommon: ‘Cardiotoxicity’ is a major side effect of anticancer treatments. Read more: https://www.washingtonpost.com/wel...